EurekAlert! -
13 Nov 2017 07:00
(American Academy of Ophthalmology) Women who took estrogen-only hormone replacement therapy after ovary removal had a lower risk of developing glaucoma, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.
Share this Article